Targeted Gene Transfer to T Lymphocytes to Inhibit Immune Activation
Author Information
Author(s): Khanna Ashwani K, Mehra Mandeep R
Primary Institution: University of Maryland, Baltimore, MD, USA
Hypothesis
Can a CD3-promoter-p21 chimeric construct effectively transfer the p21 gene to T lymphocytes to inhibit their proliferation and alloimmune activation?
Conclusion
The study demonstrates that targeted gene transfer of the p21 gene to T cells can effectively inhibit their proliferation and immune activation.
Supporting Evidence
- Transfection of CD3p21 sense and antisense in mouse thyoma cell line resulted in modulation of mitogen-induced proliferation.
- Intramuscular injection of CD3p21 plasmid DNA into mice modulated lymphocyte proliferation and mRNA expression of pro-inflammatory cytokines.
- Overexpression of p21 in lymphocytes resulted in decreased response to mitogenic stimuli.
Takeaway
Scientists are trying to stop T cells from growing too much, which can cause problems in organ transplants, by giving them a special gene that helps control their growth.
Methodology
The study used a CD3-promoter-p21 chimeric construct for gene transfer in both in vitro (EL4-IL-2 cells) and in vivo (mice) settings.
Limitations
The study did not explore the effects of p21 overexpression in specific T cell subsets such as CD4 and CD8 cells.
Participant Demographics
C57/BL-6 mice were used for in vivo studies.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website